Per Odin
131 – 140 of 161
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Effect and safety of duodenal levodopa infusion in advanced Parkinson's disease: a retrospective multicenter outcome assessment in patient routine care
(
- Contribution to journal › Article
-
Mark
A Proposal for a Comprehensive Grading of Parkinson's Disease Severity Combining Motor and Non-Motor Assessments: Meeting an Unmet Need
(
- Contribution to journal › Article
-
Mark
Reduced Body Mass Index in Parkinson's Disease: Contribution of Comorbid Depression.
(
- Contribution to journal › Article
-
Mark
Pharmacokinetics of Levodopa, Carbidopa, and 3-O-Methyldopa Following 16-hour Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease Patients
(
- Contribution to journal › Article
-
Mark
Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Nonmotor fluctuations in Parkinson disease: Severity and correlation with motor complications.
(
- Contribution to journal › Article
- 2012
-
Mark
Gender-related differences in the burden of non-motor symptoms in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Duration of L-dopa and dopamine agonist monotherapy in Parkinson´s disease
(
- Contribution to journal › Article
-
Mark
Impact of community pharmaceutical care on patient health and quality of drug treatment in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Intrajejunal Levodopa Versus Conventional Therapy in Parkinson Disease: Motor and Nonmotor Effects.
(
- Contribution to journal › Article